🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ruxolitinib for myelofibrosis: The earlier, the better?

Cancer(2024)10.1002/cncr.35592Source: DataRank Database

Ruxolitinib for myelofibrosis: The earlier, the better? is a research paper published in Cancer (2024). On theSindex it has a DataRank of 0.

N/A
0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations
Download PDF
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: bronzeTopics (10)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      Authors (2)

      Pankit VachhaniORCID,Prithviraj BoseORCID
      Live enrichment
      PubMed:39396121OpenAlex:https://openalex.org/W4403361987

      Clinical Center

      Grant: P30 CA013148

      Clinical Center

      Grant: P30 CA016672

      FWCI

      0.00

      Citation Percentile

      0.2%

      bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor
      journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35592
      publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35592
      publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.35592
      journalhttps://doi.org/10.1002/cncr.35592
      repositoryhttps://pubmed.ncbi.nlm.nih.gov/39396121

      Fields of Study

      Myeloproliferative Neoplasms: Diagnosis and TreatmentKruppel-like factors researchEosinophilic Disorders and Syndromes

      Keywords

      MyelofibrosisRuxolitinibMedicineDiseaseOncologyInternal medicineBone marrow

      Sustainable Development Goals

      SDG 0: Good health and well-being